Insulet (NSDQ:PODD) said yesterday it extended a materials and manufacturing deal with Flextronics (NSDQ:FLEX) to produce and manufacture its Omnipod insulin management system for an additional 5 years. The deal also includes Insulet’s drug delivery devices and diabetes managers, Billerica, Mass.-based Insulet said. Under the contract, manufacturing will continue at a Chinese facility owned and operated by a […]
Insulet
Ex-Abbott exec Simhambhatla is new Alphaeon CEO | Personnel Moves August 26, 2016
Ex-Abbott exec Simhambhatla is new Alphaeon CEO Healthcare and social commerce company Alphaeon said last week it tapped former Abbott (NYSE:ABT) senior veep Dr. Murthy Simhambhatla as its new CEO and president, replacing Robert Grant who was recently appointed as vice chair of the company’s board of directors. Dr. Simhambhatla previously operated as a senior partner Strathspey […]
Insulet Q2 tops the street, lifts guidance
Insulet (NSDQ:PODD) posted Street-beating numbers for its 2nd quarter, topping revenue and earnings per share expectations and lifting its full year guidance. The Billerica, Mass.-based company reported losses of $4.2 million, or 8¢ per share, on sales of $87.3 million for the 3 months ended June 30. That amounts to a 72.8% decrease in losses as […]
Insulet touts new data showing reduced A1c levels with Omnipod system | American Diabetes Assn. 2016 Scientific Sessions
Insulet (NSDQ:PODD) last week touted the publication of new data supporting the benefits of its Omnipod insulin management system, with data supporting the systems’ efficacy at controlling blood glucose levels in patients switching from daily injections or tubed insulin pumps. Data from the company’s multi-center retrospective study was used in 2 online publications in the Journal […]
Insulet updates on artificial pancreas, pipeline products
Insulet (NSDQ:PODD) said today it will present new clinical data on its artificial pancreas algorithm, new product pipeline and evidence from studies of its OmniPod system. The news is set to be presented this week at the American Diabetes Association’s 76th Scientific Sessions in New Orleans, the company said. “We are pleased to present several new […]
Insulet launches ‘Podder’ platform for Omnipod patients
Insulet (NSDQ:PODD) said today that it launched a new online platform for diabetes patients who use its Omnipod insulin management system, alongside a new mobile app and new branding for the device. “We have an incredibly engaged and active Podder community and are thrilled to now contribute and be part of the conversation on social media,” […]
Insulet shares lift on Street-beating Q1
Insulet (NSDQ:PODD) saw shares rise slightly in after-hours training after posting a Street-beating 1st quarter earnings report, despite seeing net losses increase from 2015. The diabetes-focused medtech company reported losses of $12.4 million, or 19¢ per share, on sales of $81.2 million for the 3 months ended March 31. That amounts to a 5.5% increase in […]
Flex taps ex J&J med device R&D exec Carlson for Flex Med Solutions prez | Personnel Moves April 26, 2016
Flex taps ex J&J med device R&D exec Carlson for Flex Med Solutions prez Flex (NSDQ:FLEX) said it hired ex-Johnson & Johnson (NYSE:JNJ) innovation portfolio veep as its new president of Flex Medical solutions. The position will put Carlson in charge of the company’s $8 billion research & development budget across pharmaceuticals, medical devices and consumer […]
MassDevice.com’s Personnel Moves | March 21, 2016
AdvaMed taps Cohera CEO Daly for Accel chairmanship AdvaMed said it tapped Patrick Daly, president & CEO of Cohera Medical, to be the new chairman of its AdvaMed Accel division for smaller medical device companies. Daly, who’s been on the board at Accel since 2012 and on the AdvaMed board since 2014, replaces CVRx president […]
Icahn claims success, steps back from Hologic | Personnel Moves
Billionaire investor Carl Icahn said last Friday that he will begin to ramp down his involvement with Hologic (NSDQ:HOLX), claiming his intervention with the company to be a success. As part of the stepping away process, Icahn representatives Jonathan Christodoro and Samuel Merksamer stepped down from the board and will not be replaced, according to SEC […]
Insulet’s Q4 sales surprise, but earnings miss badly
Insulet (NSDQ:PODD) yesterday surprised analysts on Wall Street with its 4th-quarter sales results, but missed the consensus earnings forecast by a wide margin. Fourth-quarter losses for the Billerica, Mass.-based company soared 406.1% to -$27.3 million, or -48¢ per share, on sales growth of 38.0% to $100.1 million compared with Q4 2014. That’s a 22¢ miss on […]